Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Renalytix Plc (RENX)

Price 30.00p on 19-04-2024 at 16:30:03
Change 0.00p 0%
Buy 31.00p
Sell 29.00p
Buy / Sell RENX Shares
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 380.00 at 29.689p
Day's Volume: 1,275
Last Close: 30.00p
Open: 30.00p
ISIN: GB00BYWL4Y04
Day's Range 30.00p - 30.00p
52wk Range: 10.25p - 145.00p
Market Capitalisation: £38m
VWAP: 29.35013p
Shares in Issue: 126m

Sector: Health Care and Related Services

Listed In: FTSE AIM All-Share,

Recent Trades History Renalytix Plc (RENX)
Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 380 29.689p Ordinary
 10:39:12 - 19-Apr-24
Sell* 10 29.70p Ordinary
 10:15:26 - 19-Apr-24
Sell* 884 29.20p Ordinary
 07:03:05 - 19-Apr-24
Sell* 1 29.79p Ordinary
 07:00:10 - 19-Apr-24

Share Price History for Renalytix Plc
Time period:
to
Date Open High Low Close Volume

Share News for Renalytix Plc

IN BRIEF: Renalytix chief business officer to become president

18th Apr 2024 11:20

Renalytix PLC - London-based diagnostics company focused on the management and testing of kidney disease through its KidneyIntelX platform - Chief Business Officer Howard Doran has been appointed as president, effective April 30. He replaces Thomas McLain, who is stepping down as president on the same date after serving in the role since July 2019. Doran has been business chief since September last year. Read More

UK shareholder meetings calendar - next 7 days

15th Apr 2024 14:09

Read More

IN BRIEF: Renalytix announces financing of up to USD4 million

8th Apr 2024 13:34

Renalytix PLC - London-based diagnostics company focused on the management and testing of kidney disease through its KidneyIntelX platform - Announces direct offer of shares at a purchase price equivalent to USD0.75 per NASDAQ American Depositary Share, or USD0.375 per common stock share, to DB Capital Partners Healthcare LP, an investor focused on innovative medical technology. Says the fundraise was conducted by way of a securities purchase agreement, consisting of an initial tranche of 2.7 million shares for USD1.0 million, and an optional subsequent tranche. If the optional tranche is exercised, Renalytix expects the total amount of financing to reach USD4 million. The price of USD0.375 per ordinary share represents a premium of roughly 4.1% to the company's closing price on Friday. Read More

TRADING UPDATES: Horizonte subsidiary hit with debt injunction

14th Mar 2024 18:26

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

IN BRIEF: Renalytix shares sink on heavily discounted placing

12th Mar 2024 13:59

Renalytix PLC - London-based diagnostics company focused on its flagship KidneyIntelX prognostic for patients with kidney disease - Launches placing for around USD10 million, or GBP7.8 million. The placing involves the issue of around 39 million shares in the company at a price of 20 pence each. This represents a roughly 28% discount to the company's Monday closing price of 38.54 pence per share. Renalytix says that issuing more than 20.0 million shares will require shareholder approval, which the company intends to seek at a general meeting, the date and time of which has yet to be confirmed. Read More

FTSE 100 Latest
Value7,895.85
Change18.80

Login to your account

Forgot Password?

Not Registered